share_log
Hi,
moomoo ID:0
Log Out
English
Back
  • English
  • 中文繁体
  • 中文简体

Livent, Amgen And Some Other Big Stocks Moving Lower On Monday

Benzinga Real-time News ·  09/12 23:11

U.S. stocks traded higher, with the Dow Jones gaining more than 250 points on Monday. Here are some big stocks recording gains in today's session.

  • DICE Therapeutics, Inc. (NASDAQ:DICE) fell 19.6% to $18.20. Stifel, last week, initiated coverage on the stock with a Buy rating and a $37 price target.
  • Entrada Therapeutics, Inc. (NASDAQ:TRDA) dropped 11.4% to $13.21. Entrada Therapeutics, last month, posted a Q2 loss of $0.74 per share.
  • ShiftPixy, Inc. (NASDAQ:PIXY) fell 9.8% to $31.06 after gaining 11% on Friday.
  • Azure Power Global Limited (NYSE:AZRE) dropped 9.3% to $5.32.
  • Immatics N.V. (NASDAQ:IMTX) fell 9% to $11.69.
  • Microvast Holdings, Inc. (NASDAQ:MVST) declined 8.3% to $2.3197.
  • Construction Partners, Inc. (NASDAQ:ROAD) fell 7.8% to $28.00.
  • Forge Global Holdings, Inc. (NYSE:FRGE) dropped 7.8% to $4.04.
  • Burning Rock Biotech Limited (NASDAQ:BNR) declined 7.2% to $3.33.
  • Humacyte, Inc. (NASDAQ:HUMA) fell 7.1% to $4.19. Humacyte recently filed for mixed-securities shelf offering of up to $300 million.
  • Couchbase, Inc. (NASDAQ:BASE) dipped 7.1% to $14.49. The company, last week, posted upbeat quarterly results.
  • Livent Corporation (NYSE:LTHM) fell 5.8% to $32.46 after Verticle Research downgraded the stock from Buy to Hold and announced a $35 price target.
  • Amgen Inc. (NASDAQ:AMGN) dropped 3.7% to $238.44 following FDA approval of Bristol Myers Squibb's plaque psoriasis drug Sotyktu, which showed superior efficacy to Amgen's Otezla.

This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors’ financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. Moomoo makes no representation or warranty as to its adequacy, completeness, accuracy or timeliness for any particular purpose of the above content.

Moomoo is a financial information and trading app offered by Moomoo Technologies Inc.
In the U.S., investment products and services available through the moomoo app are offered by Moomoo Financial Inc., a broker-dealer registered with the U.S. Securities and Exchange Commission (SEC) and a member of Financial Industry Regulatory Authority (FINRA)/Securities Investor Protection Corporation (SIPC).
In Singapore, investment products and services available through the moomoo app are offered through Moomoo Financial Singapore Pte. Ltd. regulated by the Monetary Authority of Singapore (MAS). Moomoo Financial Singapore Pte. Ltd. is a Capital Markets Services Licence (License No. CMS101000) holder with the Exempt Financial Adviser Status. This advertisement has not been reviewed by the Monetary Authority of Singapore.
In Australia, financial products and services available through the moomoo app are provided by Futu Securities (Australia) Ltd, an Australian Financial Services Licensee (AFSL No. 224663) regulated by the Australian Securities and Investment Commission (ASIC). Please read and understand our Financial Services Guide, Terms and Conditions, Privacy Policy and other disclosure documents which are available on our websites https://www.futuau.com and https://www.moomoo.com/au. Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd. and Futu Securities (Australia) Ltd are affiliated companies.